Skip to Main Content

Author Details

Hajime Otani
Kansai Medical University
1980
148
42
PMIDPaper TitleJournal TitlePublished Year
277464152016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).Endocr J2016
31245495Antagomir-92a impregnated gelatin hydrogel microsphere sheet enhances cardiac regeneration after myocardial infarction in rats.Regen Ther2016
26387649Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm.Clin Endocrinol (Oxf)2016
26408540Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.Am J Physiol Heart Circ Physiol2015
22608892Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.Int J Cardiol2013
24327827Antioxidants in longevity and medicine.Oxid Med Cell Longev2013
23738041Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease.Oxid Med Cell Longev2013
23590933Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.Int J Cardiol2013
22050707Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.J Cell Mol Med2012
23620693Granulocyte colony-stimulating factor does not enhance recruitment of bone marrow-derived cells in rats with acute myocardial infarction.Exp Clin Cardiol2012
22690898Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys.Thyroid2012
22523530Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.PLoS One2012
19709770Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.Int J Cardiol2011
30532877The case of successful catheter ablation using only the approach from the upper part of the subject's body, with meandering aorta and implanted IVC filter.J Cardiol Cases2011
30532855Retrograde fast pathway ablation with the EnSite NavX mapping system for slow-fast atrioventricular node reentrant tachycardia and a prolonged PR interval during sinus rhythm.J Cardiol Cases2011
24122584Comparison of neointimal morphology of in-stent restenosis with sirolimus-eluting stents versus bare metal stents: virtual histology-intravascular ultrasound analysis.Cardiovasc Interv Ther2011
24122503Percutaneous coronary intervention for left main trunk ostial stenosis in a patient with Takayasu's arteritis.Cardiovasc Interv Ther2011
22118755Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.Nutr Res2011
21890687Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.Am J Physiol Heart Circ Physiol2011
21554376Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.Clin Exp Pharmacol Physiol2011
21756052Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart.Free Radic Res2011
21498915Comparison of metabolic profile and adiponectin level with pioglitazone versus voglibose in patients with type-2 diabetes mellitus associated with metabolic syndrome.Endocr J2011
21083501Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.Antioxid Redox Signal2011
21074540Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.J Mol Cell Cardiol2011
21126197Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome.Antioxid Redox Signal2011
21157107Aneurysm originating from an aortopulmonary fistula with a markedly tortuous course.Circ J2011
21182845Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart.J Mol Cell Cardiol2011
20537926Phenotypic modulation and turnover of bone marrow-derived cells after myocardial infarction in rats.Cardiovasc Pathol2011
19411121Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction.Int J Cardiol2010
20877127Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase.Circ J2010
19203224The role of nitric oxide in myocardial repair and remodeling.Antioxid Redox Signal2009
18192224Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium.Am J Physiol Heart Circ Physiol2008
18484167Three-dimensional echocardiographic assessment of left ventricular function in takotsubo cardiomyopathy.Heart Vessels2008
18665799N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.Antioxid Redox Signal2008
18654025Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation.Circ J2008
18390819Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.Am J Physiol Heart Circ Physiol2008
17999631Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities.Antioxid Redox Signal2008
17188708Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat.J Mol Cell Cardiol2007
17664136Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.Free Radic Biol Med2007
17259438Exercise-induced activation of cardiac sympathetic nerve triggers cardioprotection via redox-sensitive activation of eNOS and upregulation of iNOS.Am J Physiol Heart Circ Physiol2007
17448895VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium.Free Radic Biol Med2007
16375879Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster.Cardiovasc Res2006
18651034Significance of wine and resveratrol in cardiovascular disease: French paradox revisited.Exp Clin Cardiol2006
17034353Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway.Antioxid Redox Signal2006
16998271Role of mechanical stress in the form of cardiomyocyte death during the early phase of reperfusion.Circ J2006
16910782Role of oxidative/nitrosative stress in the tolerance to ischemia/reperfusion injury in cardiomyopathic hamster heart.Antioxid Redox Signal2006
16466703Dystrophin is a possible end-target of ischemic preconditioning against cardiomyocyte oncosis during the early phase of reperfusion.Cardiovasc Res2006
16501287Effects of intravenous administration of tissue plasminogen activator before thrombectomy in patients with acute myocardial infarction.Circ J2006
16697003Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.J Mol Cell Cardiol2006
15805233Integrated pharmacological preconditioning and memory of cardioprotection: role of protein kinase C and phosphatidylinositol 3-kinase.Am J Physiol Heart Circ Physiol2005
  • 1 - 50 of 148

Recommended Authors

Christopher Lotz
University Hospital Wuerzburg
Career Start Year 2007
Number of shared co-authors 0
Nina C Weber
University Medical Centers
Career Start Year 2002
Number of shared co-authors 0
David A Liem
University of California davis
Career Start Year 2001
Number of shared co-authors 0
Junbo Ge
Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
Career Start Year 1999
Number of shared co-authors 0
Chien-Sung Tsai
Tri-Service General Hospital, National Defense Medical Center
Career Start Year 1998
Number of shared co-authors 0
Matthias L Riess
Vanderbilt University Medical Center, 1211 Medical Center Drive
Career Start Year 1997
Number of shared co-authors 0
Arnold S Baas
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
Muneaki Matsubara
Institute of Medicine, University of Tsukuba
Career Start Year 1993
Number of shared co-authors 0
Neal L Weintraub
Medical College of Georgia, Augusta University
Career Start Year 1993
Number of shared co-authors 0
Peter M Kang
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
Coert J Zuurbier
University Medical Centers
Career Start Year 1991
Number of shared co-authors 0
Jianyi Zhang
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1989
Number of shared co-authors 0
Yochai Birnbaum
Baylor College of Medicine
Career Start Year 1989
Number of shared co-authors 0
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 0
Burkert Pieske
Charite University Medicine, Berlin Institute of Health (BIH)
Career Start Year 1988
Number of shared co-authors 0
Ka Bian
University of Science and Technology of China
Career Start Year 1987
Number of shared co-authors 0
Shawn W Robinson
University of Maryland
Career Start Year 1986
Number of shared co-authors 0
Douglas B Sawyer
Center for Molecular Medicine, Maine Medical Center Research Institute
Career Start Year 1985
Number of shared co-authors 0
Christoph Thiemermann
The William Harvey Research Institute, Queen Mary University of London
Career Start Year 1984
Number of shared co-authors 0
Tetsuo Shioi
Beth Israel Deaconess Medical Center.
Career Start Year 1983
Number of shared co-authors 0
Francis X McGowan
Children's Hospital of Philadelphia
Career Start Year 1983
Number of shared co-authors 0
Michael A Portman
Seattle Children's Hospital
Career Start Year 1982
Number of shared co-authors 0
Michel Carrier
Montreal Heart Institute, University of Montreal
Career Start Year 1981
Number of shared co-authors 0
Francisco Fern??ndez-Avil??s
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 0
Steven R Houser
Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University
Career Start Year 1979
Number of shared co-authors 0
William A Baumgartner
The Academy at Johns Hopkins
Career Start Year 1977
Number of shared co-authors 0
Paul Erne
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 0
Georg Ertl
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 0
Dimitrios Th Kremastinos
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 0
Ezra A Amsterdam
University of California (Davis) Medical Center
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Dipak K Das
S.N. Bose National Centre for Basic Sciences
Co-authored papers 43
Nilanjana Maulik
University of Connecticut Health
Co-authored papers 25
Richard M Engelman
University of Massachusetts Medical School-Baystate
Co-authored papers 23
John A Rousou
Baystate Medical Center
Co-authored papers 16
Stanley Lemeshow
The Ohio State University Department of Public Health
Co-authored papers 8
M R Prasad
University of Tsukuba
Co-authored papers 7
R M Jones
University of Connecticut School of Medicine
Co-authored papers 5
Gerald A Cordis
University of Connecticut School of Medicine
Co-authored papers 4
Tetsuya Yoshida
Hokushin General Hospital
Co-authored papers 1
Motoaki Sato
Cardiovascular Research Center, University of Connecticut School of Medicine
Co-authored papers 1
Wolfgang H Dillmann
Co-authored papers 1
Joseph E Flack
Baystate Medical Center
Co-authored papers 1
Reni Kalfin
Institute of Neurobiology, Bulgarian Academy of Sciences
Co-authored papers 1
David W Deaton
Baystate Medical Center
Co-authored papers 1
Release 1.2